Ovarian cancer patients are more likely to have mental disorders than other patients. However, to our knowledge, there has been no systematic analysis of its global epidemiology. Therefore, a systematic review was conducted to identify the prevalence of depression, anxiety, and suicidal ideation in ovarian cancer patients in different countries.
Method
We searched PubMed, Embase, Elsevier ScienceDirect, China National Knowledge Infrastructure, WanFang Data Knowledge Service Platform, and Duxiu Academic Search Platform to identify observational studies on depression, anxiety, and suicidal ideation in patients with ovarian cancer published up to 30 June 2024. We estimated the prevalence of depression, anxiety, and suicidal ideation in ovarian cancer patients worldwide and by region, country, research period, and assessment scales.
Results
A total of 31 studies were identified involving 8315 ovarian cancer patients. The prevalence rates of depression and anxiety were 35% and 37%, respectively. In China, the prevalence of suicidal ideation of ovarian cancer patients was 32%. Ovarian cancer patients in Asia had the highest prevalence of depression, while those in Oceania (Australia, New Zealand, etc.) had the lowest. Additionally, the prevalence rates of depression and anxiety increased considerably worldwide after 2000 and have gradually stabilized since then.
Conclusion
This study found that the prevalence of depression and anxiety was high (more than one-third) among ovarian cancer patients. These findings underscore the need for a comprehensive study to address mental health problems in these patients, including the determination of incidence rates, investigation of regional differences, and assessment of comorbidities and treatment strategies.
González-MartínAHarterPLearyA, et al.Newly diagnosed and relapsed epithelial ovarian cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(10):833-848.
2.
ZamwarUMAnjankarAP. Aetiology, epidemiology, histopathology, classification, detailed evaluation, and treatment of ovarian cancer. Cureus. 2022;14(10):e30561.
3.
SolmiMFirthJMiolaA, et al.Disparities in cancer screening in people with mental illness across the world versus the general population: prevalence and comparative meta-analysis including 4 717 839 people. Lancet Psychiatry. 2020;7(1):52-63.
4.
WallJALipkingKSmithHJHuhWKSalterTLiangMI. Moderate to severe distress in half of ovarian cancer patients undergoing treatment highlights a need for more proactive symptom and psychosocial management. Gynecol Oncol. 2022;166(3):503-507.
5.
RobertsALRatanatharathornAChibnikLKubzanskyLDTworogerSS. Multiple types of distress are prospectively associated with increased risk of ovarian cancer. Cancer Med. 2023;12(14):15404-15413.
6.
ZhangYDingXChenJLiuYWangGHuD. Moderating effects of suicide resilience and meaning in life on the association between entrapment and suicidal ideation in Chinese patients with ovarian cancer: a cross-sectional study. BMC Psychiatry. 2023;23(1):585.
7.
WattsSPrescottPMasonJMcLeodNLewithG. Depression and anxiety in ovarian cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open. 2015;5(11):e007618.
8.
SimonettiAFerraraOMKotzalidisGD, et al.Suicide in gynecological and breast cancer: a systematic review. Psychooncology. 2024;33(10):e70007.
9.
LiberatiAAltmanDGTetzlaffJ, et al.The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.
10.
StroupDFBerlinJAMortonSC, et al.Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283(15):2008-2012.
11.
WellsGAWellsGSheaB, et al.The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Ottawa, Canada: Department of Epidemiology and Community Medicine, University of Ottawa. 2014.
12.
BoyongSZhengliY. A study on the correlation between depression and social support in patients with ovarian cancer. Contemp Nurse. 2010;(07):4-6.
13.
XiaoyanLJingZ. A study of the association between depression and social support during inpatient chemotherapy in patients with ovarian cancer. Qilu Journal of Nursing. 2006;12(9):1667-1669.
14.
GuanxiuTZhifangCYunWLiCYiCJunL. Study on the status quo and influencing factors of suicidal ideation in patients with gynecological malignant tumors. Chin Gen Pract. 2014;17(25):3005-3008.
15.
RuiYJiemanHZhaojieC. Correlation between anxiety and depression and resilience in patients with ovarian cancer. Maternal and Child Health Care in China. 2016;31(12):2438-2440.
16.
RuizhenYXianbinSMotongLC. Discussion on pretreatment emotion detection and psychological intervention in patients with ovarian malignant tumors. J Pract Med Technol. 2004;11(8):1462-1463.
17.
YananYJingCDerongL. Investigation on the status quo and influencing factors of anxiety and depression symptoms in 2121 patients undergoing gynecological surgery. Mod Prev Med. 2018;45(12):2293-2296.
18.
BisselingKCKondalsamy-ChennakesavanSBekkersRLJandaMObermairA. Depression, anxiety and body image after treatment for invasive stage one epithelial ovarian cancer. Aust N Z J Obstet Gynaecol. 2009;49(6):660-666.
19.
ChittrakulSCharoenkwanKWongpakaranN. Prevalence of anxiety may not be elevated in Thai ovarian cancer patients following treatment. Asian Pac J Cancer Prev. 2015;16(3):1251-1254.
20.
ClevengerLSchrepfADegeestK, et al.Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis. Cancer. 2013;119(17):3234-3241.
21.
CostanzoESLutgendorfSKSoodAKAndersonBSoroskyJLubaroffDM. Psychosocial factors and interleukin-6 among women with advanced ovarian cancer. Cancer. 2005;104(2):305-313.
22.
GonçalvesVJaysonGTarrierN. A longitudinal investigation of psychological morbidity in patients with ovarian cancer. Br J Cancer. 2008;99(11):1794-1801.
23.
HipkinsJWhitworthMTarrierNJaysonG. Social support, anxiety and depression after chemotherapy for ovarian cancer: a prospective study. Br J Health Psychol. 2004;9(4):569-581.
24.
HodgkinsonKButowPFuchsA, et al.Long-term survival from gynecologic cancer: psychosocial outcomes, supportive care needs and positive outcomes. Gynecol Oncol. 2007;104(2):381-389.
25.
HuSBaraghoshiDChangCP, et al.Mental health disorders among ovarian cancer survivors in a population-based cohort. Cancer Med. 2023;12(2):1801-1812.
26.
HuYMaZZhangH, et al.Prevalence of and factors related to anxiety and depression symptoms among married patients with gynecological malignancies in China. Asian J Psychiatr. 2018;37:90-95.
27.
JolyFAhmed-LechehebDKalbacherE, et al.Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study. Ann Oncol. 2019;30(5):845-852.
28.
LiavaagAHDørumAFossåSDTropéCDahlAA. Controlled study of fatigue, quality of life, and somatic and mental morbidity in epithelial ovarian cancer survivors: how lucky are the lucky ones?J Clin Oncol. 2007;25(15):2049-2056.
29.
LiuCLLiuLZhangYDaiXZWuH. Prevalence and its associated psychological variables of symptoms of depression and anxiety among ovarian cancer patients in China: a cross-sectional study. Health Qual Life Outcomes. 2017;15(1):161.
30.
MaoWLiFLiB, et al.Mental distress, quality of life and physical symptoms in Chinese women with ovarian cancer receiving olaparib treatment during the COVID-19 pandemic. Front Psychiatry. 2022;13:13.
31.
MielcarekPNowicka-SauerKKozakaJ. Anxiety and depression in patients with advanced ovarian cancer: a prospective study. J Psychosom Obstet Gynaecol. 2016;37(2):57-67.
32.
NortonTRManneSLRubinS, et al.Prevalence and predictors of psychological distress among women with ovarian cancer. J Clin Oncol. 2004;22(5):919-926.
33.
ParkerPAKudelkaABasen-EngquistKKavanaghJde MoorJCohenL. The associations between knowledge, CA125 preoccupation, and distress in women with epithelial ovarian cancer. Gynecol Oncol. 2006;100(3):495-500.
34.
PriceMAButowPNCostaDS, et al.Prevalence and predictors of anxiety and depression in women with invasive ovarian cancer and their caregivers. Med J Aust. 2010;193(S5):S52-S57.
35.
RamondettaLZhukovskyDUrbauerDBasen-EnquistKThackerPSunC. Title: factors contributing to anxiety, depression in newly diagnosed ovarian cancer patients. Support Care Cancer. 2010;18:S202.
36.
SlovacekLSlovackovaBPriesterP, et al.Depression symptoms among patients with metastatic ovarian cancer in a programme of palliative cancer care: a prospective and cross-sectional study. Palliat Med. 2010;24(4):S127.
37.
SuzukiNNinomiyaMMarutaS, et al.Psychological characteristics of Japanese gynecologic cancer patients after learning the diagnosis according to the hospital anxiety and depression scale. J Obstet Gynaecol Res. 2011;37(7):800-808.
38.
WenQShaoZZhangPZhuTLiDWangS. Mental distress, quality of life and social support in recurrent ovarian cancer patients during active chemotherapy. Eur J Obstet Gynecol Reprod Biol. 2017;216:85-91.
39.
WenzelLBDonnellyJPFowlerJM, et al.Resilience, reflection, and residual stress in ovarian cancer survivorship: a gynecologic oncology group study. Psychooncology. 2002;11(2):142-153.
40.
XuJWangXWQuP. Results of a cross-sectional study: prevalence and associated risk factors of depression in hospitalized patients with ovarian cancer. Int J Gynecol Cancer. 2022;32:A166.
41.
ZhangYDingXChenJLiuYWangGHuD. Moderating effects of suicide resilience and meaning in life on the association between entrapment and suicidal ideation in Chinese patients with ovarian cancer: a cross-sectional study. BMC Psychiatry. 2023;23(1):585.
42.
KimSYLeeYKohSB. Factors affecting the occurrence of mental health problems in female cancer survivors: a nationwide cohort study. Int J Environ Res Public Health. 2022;19(14):8615.
43.
WulzARLawRWangJWolkinAF. Leveraging data science to enhance suicide prevention research: a literature review. Inj Prev. 2022;28(1):74-80.
44.
DavisLESutradharRBourqueMA, et al.Access to symptom screening and severe symptom risk among cancer patients with major mental illness. Psychooncology. 2023;32(10):1557-1566.
45.
SpagnolettiBRMBennettLRKeenanC, et al.What factors shape quality of life for women affected by gynaecological cancer in South, South East and East Asian countries? A critical review. Reprod Health. 2022;19(1):70.
46.
DaLTarasenkoYChenC. Asian American sub-ethnic disparities and trends in epithelial ovarian cancer diagnosis, treatment and survival. Ethn Health. 2024;29(6):685-702.
47.
TeoIBhaskarAOzdemirS, et al.Perceived stigma and its correlates among Asian patients with advanced cancer: a multi-country APPROACH study. Psychooncology. 2022;31(6):938-949.
48.
VioletteCJMandelbaumRSNusbaumDJ, et al.Temporal trends and characteristics of suicide among women with gynecologic malignancy in the United States. Gynecol Oncol Rep. 2019;30:100510.
49.
CaoXLZhongBLXiangYT, et al.Prevalence of suicidal ideation and suicide attempts in the general population of China: a meta-analysis. Int J Psychiatry Med. 2015;49(4):296-308.
50.
ZhongBLLiSHLvSY, et al.Suicidal ideation among Chinese cancer inpatients of general hospitals: prevalence and correlates. Oncotarget. 2017;8(15):25141-25150.
51.
AbrolDChandelRKAliMBhagatSSharmaVK. Psychological impact of COVID-19 pandemic on cancer patients: a cross-sectional study. J Cancer Res Ther. 2023;19(3):713-719.
52.
LuWPikhartHPeaseyAKubinovaRPitmanABobakM. Risk of depressive symptoms before and after the first hospitalisation for cancer: evidence from a 16-year cohort study in the Czech Republic. J Affect Disord. 2020;276:76-83.
53.
MessEZiembowskaAStaśJMisiągWChabowskiM. Assessment of the emotional condition of women with cancer. Eur Rev Med Pharmacol Sci. 2021;25(17):5429-5435.
54.
HalletJDavisLEIsenberg-GrzedaE, et al.Gaps in the management of depression symptoms following cancer diagnosis: a population-based analysis of prospective patient-reported outcomes. Oncologist. 2020;25(7):e1098-e1108.
55.
LiuQHeHYangJFengXZhaoFLyuJ. Changes in the global burden of depression from 1990 to 2017: findings from the global burden of disease study. J Psychiatr Res. 2020;126:134-140.
56.
PitanupongJPhiromWKittichetRAnantapongK. Prevalence and associated factors of depressive symptoms among patients with cancer receiving radiotherapy in southern Thailand: a university hospital-based cross-sectional study. BMC Palliat Care. 2023;22(1):25.
57.
Bodurka-BeversDBasen-EngquistKCarmackCL, et al.Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecol Oncol. 2000;78(3 Pt 1):302-308.
58.
OstovarSModarresi ChahardehiAMohd HashimIHOthmanAKrukJGriffithsMD. Prevalence of psychological distress among cancer patients in Southeast Asian countries: a systematic review. Eur J Cancer Care. 2022;31(6):e13669.
59.
DingXWuMZhangY, et al.The prevalence of depression and suicidal ideation among cancer patients in mainland China and its provinces, 1994-2021: a systematic review and meta-analysis of 201 cross-sectional studies. J Affect Disord. 2023;323:482-489.
60.
SunXHLiuXZhangBWangYMFanL. Impact of spiritual care on the spiritual and mental health and quality of life of patients with advanced cancer. World J Psychiatry. 2021;11(8):449-462.
61.
HeYPangYSuZ, et al.Symptom burden, psychological distress, and symptom management status in hospitalized patients with advanced cancer: a multicenter study in China. ESMO Open. 2022;7(6):100595.
62.
TeoINgSBundocFG, et al.A prospective study of psychological distress among patients with advanced cancer and their caregivers. Cancer Med. 2023;12(8):9956-9965.
63.
GopalanMRKarunakaranVPrabhakaranAJayakumarKL. Prevalence of psychiatric morbidity among cancer patients - hospital-based, cross-sectional survey. Indian J Psychiatry. 2016;58(3):275-280.
64.
DeodharJKSonkusareLNGoswamiSS. Psychiatric disorders in older adults with cancer referred to psycho-oncology service in a tertiary care cancer centre: a 7-year real world experience from India. BMC Psychiatry. 2024;24(1):49.
ThinhDHQSrirajWMansorM, et al.Analgesic prescription patterns and pain outcomes in Southeast Asia: findings from the analgesic treatment of cancer pain in Southeast Asia study. J Glob Oncol. 2018;4:1-10.
67.
KrebberAMBuffartLMKleijnG, et al.Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncology. 2014;23(2):121-130.
68.
LindenWVodermaierAMackenzieRGreigD. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord. 2012;141(2-3):343-351.
69.
MejarehZNAbdollahiBHoseinipalangiZ, et al.Global, regional, and national prevalence of depression among cancer patients: a systematic review and meta-analysis. Indian J Psychiatry. 2021;63(6):527-535.
70.
MitchellAJFergusonDWGillJPaulJSymondsP. Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol. 2013;14(8):721-732.
71.
FangSXuLLiuJ, et al.Self-rated health and health-related quality of life among cancer patients: the serial multiple mediation of anxiety and depression. BMC Psychol. 2024;12(1):415.
72.
RussellGLightmanS. The human stress response. Nat Rev Endocrinol. 2019;15(9):525-534.
73.
BrownLCMurphyARLalondeCSSubhedarPDMillerAHStevensJS. Posttraumatic stress disorder and breast cancer: risk factors and the role of inflammation and endocrine function. Cancer. 2020;126(14):3181-3191.
74.
CuiBLuoYTianP, et al.Stress-induced epinephrine enhances lactate dehydrogenase A and promotes breast cancer stem-like cells. J Clin Investig. 2019;129(3):1030-1046.
75.
SuJPLiuHFZhangHLHeYJNieY. Effects of different degrees of depression on inflammatory response and immune function in patients with ovarian cancer. J Biol Regul Homeost Agents. 2018;32(5):1225-1230.
76.
ThorntonLMAndersenBLCrespinTRCarsonWE. Individual trajectories in stress covary with immunity during recovery from cancer diagnosis and treatments. Brain Behav Immun. 2007;21(2):185-194.
77.
AndersenBLFarrarWBGolden-KreutzDM, et al.Psychological, behavioral, and immune changes after a psychological intervention: a clinical trial. J Clin Oncol. 2004;22(17):3570-3580.
78.
HaghighiFGalfalvyHChenS, et al.DNA methylation perturbations in genes involved in polyunsaturated fatty acid biosynthesis associated with depression and suicide risk. Front Neurol. 2015;6:92.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
